Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 2
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean llanos o[au] (89 results)?
Type 2 inflammation in asthma and other airway diseases.
Maspero J, Adir Y, Al-Ahmad M, Celis-Preciado CA, Colodenco FD, Giavina-Bianchi P, Lababidi H, Ledanois O, Mahoub B, Perng DW, Vazquez JC, Yorgancioglu A. Maspero J, et al. Among authors: ledanois o. ERJ Open Res. 2022 Aug 1;8(3):00576-2021. doi: 10.1183/23120541.00576-2021. eCollection 2022 Jul. ERJ Open Res. 2022. PMID: 35923421 Free PMC article. Review.
Type 2 Inflammation and Asthma in Children: A Narrative Review.
Papadopoulos NG, Bacharier LB, Jackson DJ, Deschildre A, Phipatanakul W, Szefler SJ, Gall R, Ledanois O, Jacob-Nara JA, Sacks H. Papadopoulos NG, et al. Among authors: ledanois o. J Allergy Clin Immunol Pract. 2024 Sep;12(9):2310-2324. doi: 10.1016/j.jaip.2024.06.010. Epub 2024 Jun 13. J Allergy Clin Immunol Pract. 2024. PMID: 38878861 Free article. Review.
Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study.
Guilbert TW, Tolcachier A, Fiocchi AG, Katelaris CH, Phipatanakul W, Begin P, de Mir I, Altincatal A, Gall R, Ledanois O, Radwan A, Jacob-Nara JA, Deniz Y, Rowe PJ. Guilbert TW, et al. Among authors: ledanois o. J Asthma Allergy. 2024 Mar 5;17:143-159. doi: 10.2147/JAA.S416292. eCollection 2024. J Asthma Allergy. 2024. PMID: 38476213 Free PMC article.
Dupilumab 200 mg was efficacious in children (6-11 years) with moderate-to-severe asthma for up to 2 years: EXCURSION open-label extension study.
Phipatanakul W, Vogelberg C, Bacharier LB, Dell S, Altincatal A, Gall R, Ledanois O, Sacks H, Jacob-Nara JA, Deniz Y, Rowe PJ. Phipatanakul W, et al. Among authors: ledanois o. Pediatr Pulmonol. 2024 Nov;59(11):2976-2983. doi: 10.1002/ppul.27167. Epub 2024 Jul 17. Pediatr Pulmonol. 2024. PMID: 39016623 Clinical Trial.
Dupilumab Efficacy and Safety in Children With Moderate-to-Severe Asthma and High Blood Eosinophils: A Post Hoc Analysis of VOYAGE.
Jackson DJ, Hamelmann E, Roberts G, Bacharier LB, Xia C, Gall R, Ledanois O, Coleman A, Tawo K, Jacob-Nara JA, Radwan A, Rowe PJ, Deniz Y. Jackson DJ, et al. Among authors: ledanois o. J Allergy Clin Immunol Pract. 2024 Nov 27:S2213-2198(24)01179-6. doi: 10.1016/j.jaip.2024.11.014. Online ahead of print. J Allergy Clin Immunol Pract. 2024. PMID: 39613097